+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

Liver Diseases Treatment - Global Strategic Business Report - Product Thumbnail Image

Liver Diseases Treatment - Global Strategic Business Report

  • Report
  • April 2025
  • 194 Pages
  • Global
From
From
End-Stage Renal Disease - Global Strategic Business Report - Product Thumbnail Image

End-Stage Renal Disease - Global Strategic Business Report

  • Report
  • April 2025
  • 89 Pages
  • Global
From
Hepatitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Hepatitis Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 94 Pages
  • Global
From
Potassium Citrate - Global Strategic Business Report - Product Thumbnail Image

Potassium Citrate - Global Strategic Business Report

  • Report
  • April 2025
  • 182 Pages
  • Global
From
Hepatitis C Treatment - Global Strategic Business Report - Product Thumbnail Image

Hepatitis C Treatment - Global Strategic Business Report

  • Report
  • April 2025
  • 208 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Market Report 2025 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Alcoholic Hepatitis Treatment Market Report 2025 - Product Thumbnail Image

Alcoholic Hepatitis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Kidney Disease Market Report 2025 - Product Thumbnail Image

Kidney Disease Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Late Stage Chronic Kidney Disease Drugs Market Report 2025 - Product Thumbnail Image

Late Stage Chronic Kidney Disease Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Rare Kidney Diseases Market Report 2025 - Product Thumbnail Image

Rare Kidney Diseases Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Hepatitis C Market Report 2025 - Product Thumbnail Image

Hepatitis C Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Fatty Liver Treatment Market Report 2025 - Product Thumbnail Image

Fatty Liver Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Nephrology Drugs Market Report 2025 - Product Thumbnail Image

Nephrology Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Hepatorenal Syndrome Treatment Market Report 2025 - Product Thumbnail Image

Hepatorenal Syndrome Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Hepatitis Therapeutics Market Report 2025 - Product Thumbnail Image

Hepatitis Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Liver Diseases Therapeutics Market Report 2025 - Product Thumbnail Image

Liver Diseases Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Treatment Market Report 2025 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Chronic Hepatitis B Market Report 2024 - Product Thumbnail Image

Chronic Hepatitis B Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
Liver Metastases Treatment Global Market Report 2024 - Product Thumbnail Image

Liver Metastases Treatment Global Market Report 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more